SAFE Act of 2022

Summary

Save Americans from the Fentanyl Emergency Act of 2022 or the SAFE Act of 2022 This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. It limits the application of mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows a federal court to vacate or reduce the sentence for convictions of offenses involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 7 March 2022

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 7 March 2022

   Introduced

   Introduced in House

   Source: IntroReferral

3. 7 March 2022

   Introduced

   Introduced in House

   Source: IntroReferral

4. 8 March 2022

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 1 November 2022

   Referred

   Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 7 March 2022 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 7 March 2022

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 7 March 2022

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 7 March 2022

  Open at official source

Sponsors

• Chris Pappas · D · Sponsor
• Dan Newhouse · R · Sponsor
• Ted Budd · R · Sponsor
• Rep. Suozzi, Thomas R. [D-NY-3] · D · Cosponsor
• Jefferson Van Drew · R · Cosponsor
• Henry Cuellar · D · Cosponsor
• LUCILLE ROYBAL-ALLARD · D · Cosponsor
• Angie Craig · D · Cosponsor
• Abigail Spanberger · D · Cosponsor
• Tony Gonzales · R · Cosponsor
• Don Bacon · R · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → SAFE Act
• related to → Federal Initiative To Guarantee Health by Targeting Fentanyl Act
• related to → CEASE Overdose Act of 2022
• related to → SAFE Act